skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: thanks for Thursday's Market Update...the narrative and charts put reduced tapering with interest rate increases clearly in front of me...and now is making me wonder, especially about a possible window of opportunity later in the year, if I should wait until later to top up to full positions in ISRG and SYK, both heath care US stocks in a LIRA and to be held for the long-term, or do it now....what would you suggest I do or consider?.....oh, the funds used would move health care closer to the Portfolio Analytic target for this sector........thanks for the insights....Tom
Read Answer Asked by Tom on September 03, 2021
Q: hello 5i:
We've held GUD since 2014; one of the very few losers in a mostly, 5i recommended and diverse portfolio. Its shrunk to a less than 1% holding. Would you now be fine letting this go to add to a 1.5% position in WELL, realizing there may be a valuation difference? Thanks for your good work over the years. hello 5I:
just asked this question and should have included other health care holdings so you could assess properly. MRK, ABBV and VEEV in equal amounts. WELL at a smaller position. Please include this info with my previous question when answering.
thanks
Paul L
Paul L
Read Answer Asked by Paul on September 02, 2021
Q: On 8/23 FDA gave final approval to PFE re vaccine,and PFE announced acquistion of Tril for $2.26B. Initial spike to $51.36 high,but been dropping since then to close at $46.04 today.Meanwhile C Wood has been buying. Is this a good time to buy? Txs for u usual great services & views
Read Answer Asked by Peter on September 02, 2021
Q: Good Morning Peter & Team

Was looking for a good US name with some growth potential and a strong dividend and read your Aug 27 answer for John. Looked at ABBV today and it is down almost 9% and volume is almost triple the Average. In looking for news I have become confused after finding an Aug 26 article saying "AbbVie stock toppled after reporting its earnings." But it appears it didn't topple end of last week but rather, experienced the sharp decline today.

Should I be buying this on the dip? Or is there reasons to hold off for now? And if so, are there 3 other US names you might recommend which have good growth potential moving forward accompanied by a better than average dividend.

Thanks for all you do.

gm
Read Answer Asked by Gord on September 01, 2021
Q: A bit of a blast to the past....I have held on to Covalon following its dramatic decline. from a long time ago. It has been bumping up in the last while and is now over $2.00. Do you have any insight into why it has been increasing? Any thought about its prospects going forward? Would you want to add to a very small current position? Many thanks for your excellent service.
Read Answer Asked by Leonard on August 31, 2021